Research article · 2015
Conference abstract
Major challenges in formulation development: From the perspective of a developing state
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Reducing the disease burden timely and cost-effectively is one of the prime goals of every national health policy, as health and access to safe, effective, quality and affordable medicine is the basic right of people. According to the World Health Organization (WHO), the world consumption of pharmaceutical products has increased drastically from US$ 70 billion to US$ 1.1 trillion (Since 1975), with a consumption of medicines per capita growing from US$ 17 to US$ 531. Regardless of this increase in world consumption, more than 80% of all pharmaceutical products are consumed by 15% of the world population located in âÂ?Â?developed countriesâÂ?Â?. In order to mitigate this global health inequity, pharmaceutical industries of developing world need to accelerate the development and production of pharmaceutical products of optimal quality. Formulation development, being a very crucial and lengthy process, involves different pharmaceutical technologies and presents a number of challenges to the pharmaceutical industry of countries like Pakistan, India, Bangladesh, etc. Pakistani pharmaceutical market is of US$ 326 billion. In Pakistan, the major challenges that pharma industry faces while developing a new product are stricter and non-supportive pharma regulations of the national drug regulatory body that discourage new drug development, national insufficiency of research and development in producing active pharmaceutical ingredients (APIs), lack of bioequivalence and clinical trials facilities and inadequate commercial and economic feasibility regarding export of new drugs. Besides these, the complex science of drug designing which require novel technologies and well-trained talent is also a crucial challenge. This study recommend to promote harmonization of regulatory processes by adopting globally harmonized standards, establish targeted capacity-building for quality APIs, train the talent, improve research and development sector, develop bioequivalence and clinical trial facilities and set transparent pricing rules. For Pakistan, it is a high time to improve health and access to quality medicine. The recommendations in this presentation may prove helpful in improving the development rate of safe, effective, affordable and high quality drug formulations. PDF HTML Awards Nomination 0.329+ Million Readerbase
Keywords
Subjects
ChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 23 Sep 2013
Challenges of symbiotic relationship of global warming, national interest ideology of nation states and the project of a low carbon society: A developing nation?s perspective
Editorial · 2019
2020 conference(s) announcement and its PR, Major advantages/challenges of venue, subject
Conference abstract · 21 Nov 2022
Polymer chemistry is the major industry for the development of health, basic need and daily use of life, generate income, create employment, stronger economy and reduction in financial crisis, global poverty and hunger i
Opinion · 27 Sep 2022
Major Developments in Polymer Sciences
More from this journal
The newest in Polymer Sciences.
Article · 30 Dec 2024
Understanding Biomaterials: The Foundation of Modern Medicine and Biotechnology
Article · 30 Dec 2024
Understanding Monomers: The Building Blocks of Polymers
Article · 30 Dec 2024
Understanding Polymerization in Thermoplastics: The Science Behind Recyclable Materials
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPolymer Sciences
- SubjectChemistry
- BylineArticles whose byline prints “Muhammad Naeem”
